Toolkit/all-optical framework for functional testing of opsin responsiveness in cFB

all-optical framework for functional testing of opsin responsiveness in cFB

Assay Method·Research·Since 2016

Taxonomy: Technique Branch / Method. Workflows sit above the mechanism and technique branches rather than replacing them.

Summary

The all-optical framework for functional testing of opsin responsiveness in cardiac fibroblasts is an assay method described to evaluate whether virally introduced optogenetic actuators are functionally responsive in primary cFB. In the cited study, it provides an optical functional readout for opsin-expressing cardiac fibroblasts and is associated with co-culture conditions that can yield a light-sensitive excitable cardiac syncytium.

Usefulness & Problems

Why this is useful

This framework is useful for functionally verifying that delivered opsins in cardiac fibroblasts respond to light, rather than relying only on expression or delivery metrics. It supports evaluation of optogenetically modified cFB in experimental settings involving non-transformed cardiomyocyte co-culture.

Problem solved

It addresses the specific need to test whether optogenetic tools introduced into primary cardiac fibroblasts are functionally responsive. The available evidence does not indicate that the framework by itself resolves broader questions such as in vivo performance or comprehensive electrical coupling analysis.

Problem links

provides a way to test whether delivered opsins are functionally responsive in cardiac fibroblasts

Literature

It addresses the need to functionally verify that delivered optogenetic tools are responsive in the target cells.

Source:

It addresses the need to functionally verify that delivered optogenetic tools are responsive in the target cells.

Taxonomy & Function

Primary hierarchy

Technique Branch

Method: A concrete measurement method used to characterize an engineered system.

Target processes

No target processes tagged yet.

Implementation Constraints

cofactor dependency: cofactor requirement unknownencoding mode: genetically encodedimplementation constraint: context specific validationoperating role: sensor

The method requires opsin-expressing cardiac fibroblasts and an all-optical experimental setup, although the abstract-level evidence does not detail instrumentation or construct design. The cited application context includes viral delivery of optogenetic tools in primary cFB and co-culture with non-transformed cardiomyocytes.

The supplied evidence does not specify the optical hardware, stimulation wavelengths, reporter modality, quantitative performance, or which opsins were tested within this framework. Independent replication is not provided in the evidence, and validation appears limited to the reported study context.

Validation

Cell-freeBacteriaMammalianMouseHumanTherapeuticIndep. Replication

Supporting Sources

Ranked Claims

Claim 1application capabilitysupports2016Source 1needs review

Specific co-culture conditions of optogenetically modified cardiac fibroblasts with non-transformed cardiomyocytes can be used to obtain a light-sensitive excitable cardiac syncytium.

Claim 2application capabilitysupports2016Source 1needs review

Specific co-culture conditions of optogenetically modified cardiac fibroblasts with non-transformed cardiomyocytes can be used to obtain a light-sensitive excitable cardiac syncytium.

Claim 3application capabilitysupports2016Source 1needs review

Specific co-culture conditions of optogenetically modified cardiac fibroblasts with non-transformed cardiomyocytes can be used to obtain a light-sensitive excitable cardiac syncytium.

Claim 4application capabilitysupports2016Source 1needs review

Specific co-culture conditions of optogenetically modified cardiac fibroblasts with non-transformed cardiomyocytes can be used to obtain a light-sensitive excitable cardiac syncytium.

Claim 5application capabilitysupports2016Source 1needs review

Specific co-culture conditions of optogenetically modified cardiac fibroblasts with non-transformed cardiomyocytes can be used to obtain a light-sensitive excitable cardiac syncytium.

Claim 6application capabilitysupports2016Source 1needs review

Specific co-culture conditions of optogenetically modified cardiac fibroblasts with non-transformed cardiomyocytes can be used to obtain a light-sensitive excitable cardiac syncytium.

Claim 7application capabilitysupports2016Source 1needs review

Specific co-culture conditions of optogenetically modified cardiac fibroblasts with non-transformed cardiomyocytes can be used to obtain a light-sensitive excitable cardiac syncytium.

Claim 8application capabilitysupports2016Source 1needs review

Specific co-culture conditions of optogenetically modified cardiac fibroblasts with non-transformed cardiomyocytes can be used to obtain a light-sensitive excitable cardiac syncytium.

Claim 9application capabilitysupports2016Source 1needs review

Specific co-culture conditions of optogenetically modified cardiac fibroblasts with non-transformed cardiomyocytes can be used to obtain a light-sensitive excitable cardiac syncytium.

Claim 10application capabilitysupports2016Source 1needs review

Specific co-culture conditions of optogenetically modified cardiac fibroblasts with non-transformed cardiomyocytes can be used to obtain a light-sensitive excitable cardiac syncytium.

Claim 11application capabilitysupports2016Source 1needs review

Specific co-culture conditions of optogenetically modified cardiac fibroblasts with non-transformed cardiomyocytes can be used to obtain a light-sensitive excitable cardiac syncytium.

Claim 12application capabilitysupports2016Source 1needs review

Specific co-culture conditions of optogenetically modified cardiac fibroblasts with non-transformed cardiomyocytes can be used to obtain a light-sensitive excitable cardiac syncytium.

Claim 13application capabilitysupports2016Source 1needs review

Specific co-culture conditions of optogenetically modified cardiac fibroblasts with non-transformed cardiomyocytes can be used to obtain a light-sensitive excitable cardiac syncytium.

Claim 14application capabilitysupports2016Source 1needs review

Specific co-culture conditions of optogenetically modified cardiac fibroblasts with non-transformed cardiomyocytes can be used to obtain a light-sensitive excitable cardiac syncytium.

Claim 15application capabilitysupports2016Source 1needs review

Specific co-culture conditions of optogenetically modified cardiac fibroblasts with non-transformed cardiomyocytes can be used to obtain a light-sensitive excitable cardiac syncytium.

Claim 16application capabilitysupports2016Source 1needs review

Specific co-culture conditions of optogenetically modified cardiac fibroblasts with non-transformed cardiomyocytes can be used to obtain a light-sensitive excitable cardiac syncytium.

Claim 17application capabilitysupports2016Source 1needs review

Specific co-culture conditions of optogenetically modified cardiac fibroblasts with non-transformed cardiomyocytes can be used to obtain a light-sensitive excitable cardiac syncytium.

Claim 18application capabilitysupports2016Source 1needs review

Specific co-culture conditions of optogenetically modified cardiac fibroblasts with non-transformed cardiomyocytes can be used to obtain a light-sensitive excitable cardiac syncytium.

Claim 19application capabilitysupports2016Source 1needs review

Specific co-culture conditions of optogenetically modified cardiac fibroblasts with non-transformed cardiomyocytes can be used to obtain a light-sensitive excitable cardiac syncytium.

Claim 20application capabilitysupports2016Source 1needs review

Specific co-culture conditions of optogenetically modified cardiac fibroblasts with non-transformed cardiomyocytes can be used to obtain a light-sensitive excitable cardiac syncytium.

Claim 21assay capabilitysupports2016Source 1needs review

An all-optical framework is described for functional testing of opsin responsiveness in cardiac fibroblasts.

Claim 22assay capabilitysupports2016Source 1needs review

An all-optical framework is described for functional testing of opsin responsiveness in cardiac fibroblasts.

Claim 23assay capabilitysupports2016Source 1needs review

An all-optical framework is described for functional testing of opsin responsiveness in cardiac fibroblasts.

Claim 24assay capabilitysupports2016Source 1needs review

An all-optical framework is described for functional testing of opsin responsiveness in cardiac fibroblasts.

Claim 25assay capabilitysupports2016Source 1needs review

An all-optical framework is described for functional testing of opsin responsiveness in cardiac fibroblasts.

Claim 26assay capabilitysupports2016Source 1needs review

An all-optical framework is described for functional testing of opsin responsiveness in cardiac fibroblasts.

Claim 27method capabilitysupports2016Source 1needs review

Adenoviral infection can introduce ChR2(H134R) and ArchT into primary cardiac fibroblasts in vitro and yield quick, robust, and consistent expression.

Claim 28method capabilitysupports2016Source 1needs review

Adenoviral infection can introduce ChR2(H134R) and ArchT into primary cardiac fibroblasts in vitro and yield quick, robust, and consistent expression.

Claim 29method capabilitysupports2016Source 1needs review

Adenoviral infection can introduce ChR2(H134R) and ArchT into primary cardiac fibroblasts in vitro and yield quick, robust, and consistent expression.

Claim 30method capabilitysupports2016Source 1needs review

Adenoviral infection can introduce ChR2(H134R) and ArchT into primary cardiac fibroblasts in vitro and yield quick, robust, and consistent expression.

Claim 31method capabilitysupports2016Source 1needs review

Adenoviral infection can introduce ChR2(H134R) and ArchT into primary cardiac fibroblasts in vitro and yield quick, robust, and consistent expression.

Claim 32method capabilitysupports2016Source 1needs review

Adenoviral infection can introduce ChR2(H134R) and ArchT into primary cardiac fibroblasts in vitro and yield quick, robust, and consistent expression.

Claim 33method capabilitysupports2016Source 1needs review

Adenoviral infection can introduce ChR2(H134R) and ArchT into primary cardiac fibroblasts in vitro and yield quick, robust, and consistent expression.

Claim 34method capabilitysupports2016Source 1needs review

Adenoviral infection can introduce ChR2(H134R) and ArchT into primary cardiac fibroblasts in vitro and yield quick, robust, and consistent expression.

Claim 35method capabilitysupports2016Source 1needs review

Adenoviral infection can introduce ChR2(H134R) and ArchT into primary cardiac fibroblasts in vitro and yield quick, robust, and consistent expression.

Claim 36method capabilitysupports2016Source 1needs review

Adenoviral infection can introduce ChR2(H134R) and ArchT into primary cardiac fibroblasts in vitro and yield quick, robust, and consistent expression.

Claim 37method capabilitysupports2016Source 1needs review

Adenoviral infection can introduce ChR2(H134R) and ArchT into primary cardiac fibroblasts in vitro and yield quick, robust, and consistent expression.

Claim 38method capabilitysupports2016Source 1needs review

Adenoviral infection can introduce ChR2(H134R) and ArchT into primary cardiac fibroblasts in vitro and yield quick, robust, and consistent expression.

Claim 39method capabilitysupports2016Source 1needs review

Adenoviral infection can introduce ChR2(H134R) and ArchT into primary cardiac fibroblasts in vitro and yield quick, robust, and consistent expression.

Claim 40method capabilitysupports2016Source 1needs review

Adenoviral infection can introduce ChR2(H134R) and ArchT into primary cardiac fibroblasts in vitro and yield quick, robust, and consistent expression.

Claim 41method capabilitysupports2016Source 1needs review

Adenoviral infection can introduce ChR2(H134R) and ArchT into primary cardiac fibroblasts in vitro and yield quick, robust, and consistent expression.

Claim 42method capabilitysupports2016Source 1needs review

Adenoviral infection can introduce ChR2(H134R) and ArchT into primary cardiac fibroblasts in vitro and yield quick, robust, and consistent expression.

Claim 43method capabilitysupports2016Source 1needs review

Adenoviral infection can introduce ChR2(H134R) and ArchT into primary cardiac fibroblasts in vitro and yield quick, robust, and consistent expression.

Claim 44method capabilitysupports2016Source 1needs review

Adenoviral infection can introduce ChR2(H134R) and ArchT into primary cardiac fibroblasts in vitro and yield quick, robust, and consistent expression.

Claim 45method capabilitysupports2016Source 1needs review

Adenoviral infection can introduce ChR2(H134R) and ArchT into primary cardiac fibroblasts in vitro and yield quick, robust, and consistent expression.

Claim 46method capabilitysupports2016Source 1needs review

Adenoviral infection can introduce ChR2(H134R) and ArchT into primary cardiac fibroblasts in vitro and yield quick, robust, and consistent expression.

Claim 47method generalizabilitysupports2016Source 1needs review

Adjusting multiplicity of infection and virus incubation duration is presented as a way to generalize the adenoviral infection method across different lab settings or cell types.

Claim 48method generalizabilitysupports2016Source 1needs review

Adjusting multiplicity of infection and virus incubation duration is presented as a way to generalize the adenoviral infection method across different lab settings or cell types.

Claim 49method generalizabilitysupports2016Source 1needs review

Adjusting multiplicity of infection and virus incubation duration is presented as a way to generalize the adenoviral infection method across different lab settings or cell types.

Claim 50method generalizabilitysupports2016Source 1needs review

Adjusting multiplicity of infection and virus incubation duration is presented as a way to generalize the adenoviral infection method across different lab settings or cell types.

Claim 51method generalizabilitysupports2016Source 1needs review

Adjusting multiplicity of infection and virus incubation duration is presented as a way to generalize the adenoviral infection method across different lab settings or cell types.

Claim 52method generalizabilitysupports2016Source 1needs review

Adjusting multiplicity of infection and virus incubation duration is presented as a way to generalize the adenoviral infection method across different lab settings or cell types.

Claim 53method generalizabilitysupports2016Source 1needs review

Adjusting multiplicity of infection and virus incubation duration is presented as a way to generalize the adenoviral infection method across different lab settings or cell types.

Claim 54method generalizabilitysupports2016Source 1needs review

Adjusting multiplicity of infection and virus incubation duration is presented as a way to generalize the adenoviral infection method across different lab settings or cell types.

Claim 55method generalizabilitysupports2016Source 1needs review

Adjusting multiplicity of infection and virus incubation duration is presented as a way to generalize the adenoviral infection method across different lab settings or cell types.

Claim 56method generalizabilitysupports2016Source 1needs review

Adjusting multiplicity of infection and virus incubation duration is presented as a way to generalize the adenoviral infection method across different lab settings or cell types.

Claim 57method generalizabilitysupports2016Source 1needs review

Adjusting multiplicity of infection and virus incubation duration is presented as a way to generalize the adenoviral infection method across different lab settings or cell types.

Claim 58method generalizabilitysupports2016Source 1needs review

Adjusting multiplicity of infection and virus incubation duration is presented as a way to generalize the adenoviral infection method across different lab settings or cell types.

Claim 59method generalizabilitysupports2016Source 1needs review

Adjusting multiplicity of infection and virus incubation duration is presented as a way to generalize the adenoviral infection method across different lab settings or cell types.

Claim 60method generalizabilitysupports2016Source 1needs review

Adjusting multiplicity of infection and virus incubation duration is presented as a way to generalize the adenoviral infection method across different lab settings or cell types.

Claim 61method generalizabilitysupports2016Source 1needs review

Adjusting multiplicity of infection and virus incubation duration is presented as a way to generalize the adenoviral infection method across different lab settings or cell types.

Claim 62method generalizabilitysupports2016Source 1needs review

Adjusting multiplicity of infection and virus incubation duration is presented as a way to generalize the adenoviral infection method across different lab settings or cell types.

Claim 63method generalizabilitysupports2016Source 1needs review

Adjusting multiplicity of infection and virus incubation duration is presented as a way to generalize the adenoviral infection method across different lab settings or cell types.

Claim 64method generalizabilitysupports2016Source 1needs review

Adjusting multiplicity of infection and virus incubation duration is presented as a way to generalize the adenoviral infection method across different lab settings or cell types.

Claim 65method generalizabilitysupports2016Source 1needs review

Adjusting multiplicity of infection and virus incubation duration is presented as a way to generalize the adenoviral infection method across different lab settings or cell types.

Claim 66method generalizabilitysupports2016Source 1needs review

Adjusting multiplicity of infection and virus incubation duration is presented as a way to generalize the adenoviral infection method across different lab settings or cell types.

Comparisons

Source-backed strengths

A key strength is that the method is explicitly all-optical, enabling functional testing of opsin responsiveness in cFB without a non-optical readout being described in the provided evidence. The associated study also reports that specific co-culture conditions with non-transformed cardiomyocytes can produce a light-sensitive excitable cardiac syncytium.

all-optical framework for functional testing of opsin responsiveness in cFB and Field-domain rapid-scan EPR at 240 GHz address a similar problem space.

Shared frame: same top-level item type

all-optical framework for functional testing of opsin responsiveness in cFB and fluorescence line narrowing address a similar problem space.

Shared frame: same top-level item type

all-optical framework for functional testing of opsin responsiveness in cFB and native green gel system address a similar problem space.

Shared frame: same top-level item type

Strengths here: looks easier to implement in practice.

Ranked Citations

  1. 1.
    ProtocolSource 1Methods in molecular biology2016Claim 15Claim 20Claim 18

    Seeded from load plan for claim c4.